Evidence map›Paper›PMID 32620121›Full record

ArticleBMC biology2020

Real-time tracking of stem cell viability, proliferation, and differentiation with autonomous bioluminescence imaging.

Michael Conway, Tingting Xu, Andrew Kirkpatrick, Steven Ripp, Gary Sayler, Dan Close

Abstract read
In one paragraph

Article in BMC biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Bioluminescent Systems for Theranostic Applications.International journal of molecular sciences · 2024
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Bacterial bioluminescence assay for bioanalysis and bioimaging.Analytical and bioanalytical chemistry · 2022
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Bioluminescence-Driven Optogenetics.Life (Basel, Switzerland) · 2020
    Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Michael Conway490 BioTech, Knoxville, TN, 37996, USA.
Tingting XuCenter for Environmental Biotechnology, The University of Tennessee, Knoxville, TN, 37996, USA.
Andrew Kirkpatrick490 BioTech, Knoxville, TN, 37996, USA.
Steven Ripp490 BioTech, Knoxville, TN, 37996, USA.
Gary Sayler490 BioTech, Knoxville, TN, 37996, USA.
Dan Close490 BioTech, Knoxville, TN, 37996, USA. dan.close@490biotech.com.ORCID 0000-0003-4790-4448

Funding

Expressing humanized bacterial luciferase in stem cells: Moving beyond fireflyluciferase to expand the informational capacity of animal models for regenerativemedicineR42GM116622 · NIGMS · 490 BIOTECH, INC. · PI MORRISON, DAN · 2017 to 2018
$994k
Expanding the throughput of real-time toxicological screening of cardiac differentiation by expressing a synthetic luciferase/luciferin genetic pathway in iPSCsR44ES026269 · NIEHS · 490 BIOTECH, INC. · PI MORRISON, DAN · 2019 to 2020
$991k
National Science Foundation 1530953NIEHS NIH HHS R44 ES026269NIGMS NIH HHS R42 GM116622
6 · The paper itself

Abstract

backgroundLuminescent reporter proteins are vital tools for visualizing cells and cellular activity. Among the current toolbox of bioluminescent systems, only bacterial luciferase has genetically defined luciferase and luciferin synthesis pathways that are functional at the mammalian cell temperature optimum of 37 °C and have the potential for in vivo applications. However, this system is not functional in all cell types, including stem cells, where the ability to monitor continuously and in real-time cellular processes such as differentiation and proliferation would be particularly advantageous.

resultsWe report that artificial subdivision of the bacterial luciferin and luciferase pathway subcomponents enables continuous or inducible bioluminescence in pluripotent and mesenchymal stem cells when the luciferin pathway is overexpressed with a 20-30:1 ratio. Ratio-based expression is demonstrated to have minimal effects on phenotype or differentiation while enabling autonomous bioluminescence without requiring external excitation. We used this method to assay the proliferation, viability, and toxicology responses of iPSCs and showed that these assays are comparable in their performance to established colorimetric assays. Furthermore, we used the continuous luminescence to track stem cell progeny post-differentiation. Finally, we show that tissue-specific promoters can be used to report cell fate with this system.

conclusionsOur findings expand the utility of bacterial luciferase and provide a new tool for stem cell research by providing a method to easily enable continuous, non-invasive bioluminescent monitoring in pluripotent cells.

Indexed as

Cell DifferentiationCell ProliferationCell SurvivalCell LineFibroblastsHumansLuminescent MeasurementsLuminescent ProteinsStem CellsLuminescent ProteinsAutobioluminescenceBacterial luciferaseBioimagingiPSCLuciferaseLuciferinLuxMSCStem cells

Identifiers

PMID32620121
PMCPMC7333384

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.